Chardan Capital Believes Ehealth (EHTH) Won’t Stop Here
Chardan Capital analyst Steven Wardell reiterated a Buy rating on Ehealth (EHTH) today and set a price target of $129. The company’s shares closed yesterday at $103.75, close to its 52-week high of $112.22.
“We like the continued strong growth in the Medicare segment and Management’s execution. We continue to see the company being well positioned to take advantage of market trends including secular Medicare growth and shift in senior buying patterns to online. We see the company as attractively valued compared to its high- growth digital health peers and we raise our 12-month $129, giving the stock over 20% upside.”
Wardell has an average return of 74.5% when recommending Ehealth.
According to TipRanks.com, Wardell is ranked #555 out of 5253 analysts.
Currently, the analyst consensus on Ehealth is a Strong Buy with an average price target of $129.20, which is a 24.5% upside from current levels. In a report issued on July 19, First Analysis also initiated coverage with a Buy rating on the stock with a $106 price target.
See today’s analyst top recommended stocks >>
Ehealth’s market cap is currently $2.35B and has a P/E ratio of 350.86. The company has a Price to Book ratio of 5.27.
Based on the recent corporate insider activity of 75 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
eHealth, Inc. engages in the provision of Internet-based health insurance agency services for individuals, families, and small businesses. It operates through the Medicare and Individual, Family, and Small Business segment. The Medicare segment consists primarily of commissions earned from sale of Medicare-related health insurance plans.